New Amplitude fund looks to bet over $100 million on incipient Canadian biotech market
Two top Canadian venture capitalists and the Business Development Bank of Canada have raised over $70 million for a new fund aimed sharply at funding promising ideas emerging from the “under-funded” Canadian biopharma and healthcare sector.
Jean-François Pariseau and Dion Madsen have spun out their healthcare division of BDC Capital into the Amplitude fund. They’ve raised over CAD $100 million ($76 million USD) with a goal of CAD $200 million ($152 million USD), to bolster precision medicine north of the 49th parallel.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.